Join a webinar and learn more about VIBATIV® (telavancin)!

October 29, 2024

Cumberland Pharmaceuticals, manufacturer of VIBATIV® (telavancin), will be hosting a webinar titled: "Telavancin Unveiled: Optimizing Inpatient and Outpatient Care with Proven Efficacy, Safety, and Cost Benefits" to explore how telavancin can enhance patient outcomes in both inpatient and outpatient settings.

On Monday, November 18 at 11:30 a.m. CT (9:30 a.m. PT), join Dr. Alan Bulbin, MD (Director of Infectious Diseases, Chief Infection Control Officer, Director of Antimicrobial Stewardship - St. Francis Hospital) and Jason Makii, PharmD(Medical Science Liaison - Cumberland Pharmaceuticals) as they share valuable insights and discuss real-world experience with telavancin.

Date Time
Monday, November 18 11:30 a.m. CT (9:30 a.m. PT)
Register Now

Can’t attend the live session? Register to receive a recording after the presentation!


FFF Enterprises is the exclusive distributor of the VIBATIV® (telavancin) 4-Pak, consisting of four individually packaged 750 mg single-dose vials of telavancin for injection.

We appreciate your partnership and thank you for trusting FFF to fulfill your pharmaceutical product needs. Together, we are Helping Healthcare Care®.

*Click to view full Prescribing Information for VIBATIV® (telavancin) for injection and Important Safety Information.


Complimentary Resources

FFF product Catalog
FFF Product Reference Charts
Biosupply Trends Quarterly